| 000 | 01718 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516201251.0 | ||
| 264 | 0 | _c20150410 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1532-3080 | ||
| 024 | 7 |
_a10.1016/j.breast.2014.01.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCiruelos, Eva | |
| 245 | 0 | 0 |
_aThe therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer. _h[electronic resource] |
| 260 |
_bBreast (Edinburgh, Scotland) _cJun 2014 |
||
| 300 |
_a201-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xpharmacology |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xtherapeutic use |
| 700 | 1 | _aPascual, Tomás | |
| 700 | 1 | _aArroyo Vozmediano, María Luisa | |
| 700 | 1 | _aBlanco, Marta | |
| 700 | 1 | _aManso, Luis | |
| 700 | 1 | _aParrilla, Lucía | |
| 700 | 1 | _aMuñoz, Cesar | |
| 700 | 1 | _aVega, Estela | |
| 700 | 1 | _aCalderón, Monica Jackelin | |
| 700 | 1 | _aSancho, Blanca | |
| 700 | 1 | _aCortes-Funes, Hernán | |
| 773 | 0 |
_tBreast (Edinburgh, Scotland) _gvol. 23 _gno. 3 _gp. 201-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.breast.2014.01.016 _zAvailable from publisher's website |
| 999 |
_c23604293 _d23604293 |
||